EI
BIO icon

Ellevest Inc’s Bio-Rad Laboratories Class A BIO Stock Holding History

Ellevest Inc’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-25
Closed -$12K – 518
2023
Q1 		$12K Sell
25
-3
-11% -$1.4K ﹤0.01% 992
2022
Q4 		$11.8K Sell
28
-188
-87% -$75.9K ﹤0.01% 990
2022
Q3 		$90K Buy
216
+168
+350% +$83.8K 0.01% 439
2022
Q2 		$24K Buy
+48
New +$25K ﹤0.01% 721
2020
Q4 		– Sell
-48
Closed -$25K – 1195
2020
Q3 		$25K Sell
48
-12
-20% -$6.08K ﹤0.01% 483
2020
Q2 		$27K Sell
60
-20
-25% -$8.83K 0.01% 444
2020
Q1 		$28K Buy
80
+6
+8% +$2.21K 0.01% 361
2019
Q4 		$27K Buy
+74
New +$26.1K 0.01% 354

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Ellevest Inc's BIO Position: Q2 2023 in Review

Ellevest Inc sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2023, closing a stake of 25 shares — an estimated $12K sold.

Ellevest Inc first reported a position in BIO in Q4 2019 and held it in 8 quarters. The position peaked at $90K in Q3 2022. 469 funds tracked by Wall St. Rank hold BIO as of Q2 2023.

  • Ellevest Inc reported no remaining Bio-Rad Laboratories Class A position as of Q2 2023 after selling out during the quarter.
  • Ellevest Inc sold 25 Bio-Rad Laboratories Class A shares in Q2 2023, an estimated $12K.
  • Ellevest Inc first reported a position in Bio-Rad Laboratories Class A in Q4 2019 and held it in 8 quarters.
  • Ellevest Inc's Bio-Rad Laboratories Class A position peaked at $90K in Q3 2022.
  • 469 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2023.

Based on Ellevest Inc's 13F filing for Q2 2023, filed 9 Aug 2023.